Benzinga | Aug 4, 2021 04:34PM EDT

DermTech Q2 EPS $(0.59) Misses $(0.53) Estimate, Sales $3.12M Beat $2.85M Estimate

DermTech (NASDAQ:DMTK) reported quarterly losses of $(0.59) per share which missed the analyst consensus estimate of $(0.53) by 11.32 percent. This is a 1.72 percent decrease over losses of $(0.58) per share from the same period last year. The company reported quarterly sales of $3.12 million which beat the analyst consensus estimate of $2.85 million by 9.44 percent. This is a 269.55 percent increase over sales of $844.00 thousand the same period last year.